metab iv adrenal)
TRANSCRIPT
-
8/2/2019 Metab IV Adrenal)
1/119
Hormones
-
8/2/2019 Metab IV Adrenal)
2/119
Anterior Pituitary Disorders
Acromegaly
Excessive growth hormone (GH)
-
8/2/2019 Metab IV Adrenal)
3/119
Risk factors
None
Etiology
Anterior Pituitary adenoma; abnormalhypothalamic function (rare)
May demonstrate hyperglycemia; inacromegaly, GH level remains increased.
-
8/2/2019 Metab IV Adrenal)
4/119
Diagnostic Procedures
X-ray
x-ray of the skull may show thickening of thebones and enlargement of the nasal sinuses
x-rays of the hands show thickening of the
bones under the fingertips and swelling of thetissue around the bones
Blood Test
The diagnosis is confirmed by blood tests,which usually show high levels of both growthhormone and insulin-like growth factor
-
8/2/2019 Metab IV Adrenal)
5/119
CT Scan
usually done to look for abnormal growths inthe pituitary gland
Because acromegaly is usually present forsome years before being diagnosed, a tumoris seen on these scans in most people.
-
8/2/2019 Metab IV Adrenal)
6/119
Clinical Manifestations
excessive production of growth hormone begins betweenthe ages of 30 and 50, long after the growth plates of thebones have closed
Bones become deformed rather than elongated
Facial features become coarse, and the hands and feetswell
Overgrowth of the jawbone (mandible) can cause the jawto protrude (prognathism).
Cartilage in the voice box (larynx) may thicken, making thevoice deep and husky.
The ribs may thicken, creating a barrel chest.
Joint pain The tongue may enlarge and become more furrowed
Coarse body hair, which typically darkens, increases asthe skin thickens
-
8/2/2019 Metab IV Adrenal)
7/119
The sebaceous and sweat glands in the skin enlarge,producing excessive perspiration and often an offensive bodyodorThe heart usually enlarges, and its function may be so
severely impaired that heart failure occursSometimes a person feels disturbing sensations andweakness in the arms and legs as enlarging tissues compressthe nervesNerves that carry messages from the eyes to the brain may
also be compressed, causing loss of vision, particularly in theouter visual fieldsThe pressure on the brain may also cause severe headaches.irregular menstrual cyclesProduction of breast milk even though not breastfeeding(galactorrhea) because of either too much growth hormone ora related increase in prolactinAbout one third of men who have acromegaly develop erectiledysfunctionLife expectancy is reduced in people with untreatedacromegaly
-
8/2/2019 Metab IV Adrenal)
8/119
-
8/2/2019 Metab IV Adrenal)
9/119
-
8/2/2019 Metab IV Adrenal)
10/119
-
8/2/2019 Metab IV Adrenal)
11/119
Radiation therapy
involves the use of supervoltage irradiation
This treatment may take several years tohave its full effect, however, and oftenresults in later deficiencies of other pituitaryhormones, as normal tissue is often also
affected
-
8/2/2019 Metab IV Adrenal)
12/119
Drug therapy
Also used to lower growth hormone levelsbromocriptine (Parlodel) and other drugs that act likedopamine
somatostatin, the hormone that normally blocks
growth hormone production and secretion octreotide (Sandostatin) which only have to be given
about once a month
These drugs are effective in controlling acromegaly in
many people as long as they continue to be taken(they do not provide a cure)
-
8/2/2019 Metab IV Adrenal)
13/119
Gigantism
excessive secretion of growth hormone duringchildhood, before the closure of the bone
growth plates
excess growth hormone causes overgrowth ofthe long bones and very tall stature.
-
8/2/2019 Metab IV Adrenal)
14/119
Causes
benign pituitary gland tumor If excessive secretion of growth hormone
occurs after normal bone growth has stopped,the condition is known as acromegaly
The vertical growth in height that marks thiscondition is also accompanied by growth inmuscles and organs, which makes the child
extremely large for his or her age. Thedisorder can also delay puberty
Gigantism is very rare
-
8/2/2019 Metab IV Adrenal)
15/119
Manifestations: Excessive growth during childhood
Frontal bossing and a prominent jaw
Thickening of the facial features
Disproportionately large hands and feet with thickfingers and toes
Increased perspiration
Weakness
Secretion of breast milk
Irregular menstruation
Headache
Delayed onset of puberty
Double vision or difficulty with peripheral vision
-
8/2/2019 Metab IV Adrenal)
16/119
-
8/2/2019 Metab IV Adrenal)
17/119
Exams and Tests
increase in insulin growth factor-I (IGF-I) levels failure to suppress serum growth hormone (GH)
levels after an oral glucose challenge (maximum 75g)
CT or MRI scan of the head showing pituitary tumor
High prolactin levels Other hormone levels may be low due to damage to
the pituitary, including thyroid hormone, testosterone(boys), stradiol (girls), or cortisol.
-
8/2/2019 Metab IV Adrenal)
18/119
Treatment In pituitary tumors with well-defined borders, surgery is the
treatment of choice and is curative is about 80% of cases. For situations in which surgery cannot completely remove
the tumor, medication is the treatment of choice. The mosteffective medications are somatostatin analogs (such asoctreotide or long-acting lanreotide), which reduce growthhormone secretion.
Dopamine agonists (bromocriptine mesylate, cabergoline)have also been used to reduce growth hormone secretion,but these are generally less effective.
Radiation therapy has also been used to normalize growthhormone levels. However, it can take 5-10 years for the fulleffects to be seen and is almost always associated with
deficiencies in other pituitary hormones. In addition,radiation has been associated with learning disabilities,obesity, and emotional changes in children. Most expertswill use radiation only if surgery and medication fail.
-
8/2/2019 Metab IV Adrenal)
19/119
Possible Complications The development of secondary sexual
characteristics may be delayed.
Surgery and radiation can both lead todeficiencies in other pituitary hormones,causing hypothyroidism, adrenal insufficiency,hypogonadism, and (rarely) diabetes
insipidus.
-
8/2/2019 Metab IV Adrenal)
20/119
Dwarfism
the result of the disproportionate growth of the skeleton.In most cases, dwarfism is genetically determined. We
refer to those affected as "Little People." A dwarf is a person of short stature - under 4 10 as an
adult.
More than 200 different conditions can cause dwarfism.A single type, called achondroplasia, causes about 70
percent of all dwarfism. Achondroplasia is a genetic condition that affects about
1 in 25,000 people. It makes arms and legs short incomparison to the head and trunk. Other geneticconditions, kidney disease and problems withmetabolism or hormones can also cause short stature.
Dwarfism itself is not a disease. However, there is agreater risk of some health problems. With propermedical care, most people with dwarfism have active
lives and live as long as other people
-
8/2/2019 Metab IV Adrenal)
21/119
Etiology
Family history and parent's stature are usually notrelevant to the child's dwarfism.
genetic mutations at the moment of conception random combination of two recessive genes that may
have been dormant for generations
-
8/2/2019 Metab IV Adrenal)
22/119
Signs and Symptoms
In general, the disorders are divided into twobroad categories.
Disproportionare dwarfismProportionate dwarfism
-
8/2/2019 Metab IV Adrenal)
23/119
Disproportionate dwarfism
If body size is disproportionate, some parts ofthe body are small and others are of averagesize or above-average size. Disorders causingdisproportionate dwarfism inhibit the
development of bones.Characteristics: The person has an average-size trunk and very short
limbs, but some people may have a very short trunkand shortened (but disproportionately large) limbs.
The other common characteristic of these disorders isthe head being disproportionately larger than thebody.
-
8/2/2019 Metab IV Adrenal)
24/119
Almost all people with disproportionate dwarfismhave normal intellectual capacities. Rareexceptions are usually the result of a secondary
factor, such as excess fluid in the brain(hydrocephalus).
About 70 percent of all people with dwarfismhave a disorder called chondroplasia, which
causes disproportionately short stature. Thisdisorder usually results in:
-
8/2/2019 Metab IV Adrenal)
25/119
An adult height of approximately 4 feet
An average-size trunk Short arms and legs, with particularly short upper
arms and legs
Short fingers, often with a wide separation between
the middle and ring fingers Limited mobility at the elbows
A disproportionately large head, with a prominentforehead and flattened bridge of the nose
Progressive development of bowed legs (genuvarum) Progressive development of swayed lower back
(lordosis)
-
8/2/2019 Metab IV Adrenal)
26/119
Proportionate dwarfism
A body is proportionately small if all parts of the body
are small to the same degree and appear to beproportioned like a body of average stature.
Proportionate dwarfism results from medicalconditions present at birth or during early childhood
that limit overall growth and development. Therefore,the head, trunk and limbs are all small but of averageproportions relative to each other.
Most of these disorders are uncommon, and signs
and symptoms of the disorders vary greatly. A fewdisorders causing proportionate dwarfism result inmental retardation.
-
8/2/2019 Metab IV Adrenal)
27/119
Growth hormone deficiency is a relativelycommon cause of proportionate dwarfism. It
occurs when the pituitary gland fails toproduce an adequate supply of growthhormone, which is essential for regularchildhood growth. Signs and symptoms
include:Height below the fifth percentile on standardpediatric growth charts
Slowed growth before age 5
Periods of little or no change in height
Adult height usually less than 5 feet
Delayed or no sexual development duringadolescence
-
8/2/2019 Metab IV Adrenal)
28/119
-
8/2/2019 Metab IV Adrenal)
29/119
-
8/2/2019 Metab IV Adrenal)
30/119
-
8/2/2019 Metab IV Adrenal)
31/119
Intervention
The orthopaedic effects of dwarfism requirecomplex reconstructive surgery and extensive
physical therapy. Much like the severeaccident victim, surgery on Little Peopleinvolves bone grafts, fusions, steel screws,pins and plates, then months of physical
therapy to regain even the most basic functionlike walking.
-
8/2/2019 Metab IV Adrenal)
32/119
Nursing Management
Families of Little People sacrifice greatly toimprove the quality of their children's lives.Medical bills, transportation, multiplehospitalizations and operations, and months
spent in casts can take their toll emotionally,economically, and physically on the entirefamily
provide the family with the support they needto endure these trying times, knowing thattheir goals are attainable and worthwhile
-
8/2/2019 Metab IV Adrenal)
33/119
Hypergonadism
A clinical state resulting from enhanced
secretion of gonadal hormones. A condition of increased hormone production
before puberty, which produces precocioussexual development in both sexes.
-
8/2/2019 Metab IV Adrenal)
34/119
Causes
Male: Unknown causes, testicular tumors, andpituitary tumors.
Female: primarily due to idiopathic causes.
Uncommon causes include ovarian andadrenal tumors.
Diagnosis
Confirmed by positive clinical history bloodtesting for evidence of elevated sexhormones.
-
8/2/2019 Metab IV Adrenal)
35/119
Male
Onset of puberty usually occurs around age
13 with Hypergonadism, this development occurs
before age 10
Signs of precocious sexual developmentinclude:
growth of a beard and pubic hair
enlargement of the penis and the testes
Rapid growth of muscle and bone leads to earlyuniting of the epiphyses and a premature stoppageof growth in the long bones.
-
8/2/2019 Metab IV Adrenal)
36/119
Female
In the female, onset of puberty, usually occursaround the age of 10
with hypergonadism, this development occursbefore age 8.
Signs of precocious sexual developmentinclude:
onset of menarche
appearance of pubic and underarm hair
breast enlargement
Ovarian development renders the individual fertile,making pregnancy possible.
-
8/2/2019 Metab IV Adrenal)
37/119
Hypogonadism
condition more prevalent in males in whichthe production of sex hormones and germ
cells are inadequate.
-
8/2/2019 Metab IV Adrenal)
38/119
Boys: Hypogonadism most often shows up as an
abnormality in boys during puberty
Kallmann's syndrome is a birth defect in thebrain that prevents release of hormones andappears as failure of male puberty.
The childhood disease- Mumps, if acquired
after puberty, can infect and destroy thetesticlesa disease called viral orchitis
-
8/2/2019 Metab IV Adrenal)
39/119
Ionizing radiation and chemotherapy, trauma,several drugs (spironolactone, a diuretic andketoconazole, an antifungal agent), alcohol,
marijuana, heroin, methadone, andenvironmental toxins can all damage testiclesand decrease their hormone production.
-
8/2/2019 Metab IV Adrenal)
40/119
Females:
Female problems in puberty are not causedby too little estrogen. Even female
reproductive problems are rarely related to asimple lack of hormones, but rather tocomplex cycling rhythms gone wrong. All theproblems with too little hormone happen
during menopause, which is a normalhypogonadism.
-
8/2/2019 Metab IV Adrenal)
41/119
Manifestations The penis may be small, the testicles undescended
(cryptorchidism) or various degrees of "feminization"of the genitals may be present.
Besides the tissue changes generated by hormonestimulation, the only other symptoms relate to sexualdesire and function. Libido is enhanced bytestosterone, and male sexual performance requiresandrogens. The role of female hormones in female
sexual activity is less clear, although hormonesstrengthen tissues and promote healthy secretions,facilitating sexual activity.
-
8/2/2019 Metab IV Adrenal)
42/119
-
8/2/2019 Metab IV Adrenal)
43/119
Treatment:
Replacement of missing body chemicals.
Estrogen replacement is recommended for nearly allwomen after menopause for its many beneficialeffects.
Estrogen can be taken by mouth, injection, or skinpatch. It is strongly recommended that the otherfemale hormone, progesterone, be taken as well,because it prevents overgrowth of uterine lining and
uterine cancer.
Testosterone replacement is available for males whoare deficient
-
8/2/2019 Metab IV Adrenal)
44/119
Posterior Pituitary Disorders
Posterior pituitary dysfunction include specificdisorders involving oversecretion orundersecretion of ADH.
Diabetes Insipidus, caused by undersecretion ofADH, results in excessive dilute urine production.
Syndrome of Inappropriate ADH (SIADH),involving oversecretion of ADH, results inexcessive water conservation.
-
8/2/2019 Metab IV Adrenal)
45/119
Etiology
Diabetes Insipidus
Posterior pituitary destruction of tumors
Vascular accidents
Surgery or hypothalamic damage
Certain drugs that interfere with ADHsecretion or action (e.g., phenytoin, alcohol,
lithium carbonate) Nephrologenic diabetes insipidus, familial or
arising from various renal disorders
-
8/2/2019 Metab IV Adrenal)
46/119
SIADH
Central nervous system disorders
Stimulation due to hypoxia or decreased leftatrial filling pressure
Overuse of vasopressin therapy
Ectopic ADH production associated withsome cancers
Nausea or narcotic use, which can stimulateADH secretion
-
8/2/2019 Metab IV Adrenal)
47/119
Pathophysiology
Diabetes Insipidus occurs when injury to theposterior pituitary gland causes a decrease invasopressin, also known as ADH, secretion oran inability of the kidney tubules to respond toADH.
In SIADH, the basic pathologic disturbancesare excessive ADH activity, with water
retention and dilutional hyponatremia, andinappropriate urinary excretion of sodium inthe presence of hyponatremia.
-
8/2/2019 Metab IV Adrenal)
48/119
Assessment Findings
Clinical Manifestations
Diabetes Insipidus
Profoundly increased output (5-20 L/day)
Nocturia
Extreme thristWeight loss
Possible tachycardia, hypotension, andweakness
-
8/2/2019 Metab IV Adrenal)
49/119
SIADH
Decreased urine output
Weight gain
Altered mental status (e.g. headache, confusion,lethargy, seizures, and coma in severehyponatremia)
Delayed deep tendon reflex
-
8/2/2019 Metab IV Adrenal)
50/119
Laboratory and diagnostic study findings
Diabetes InsipidusPlasma osmolality and serum sodium levels areelevated
Water (fluid) deprivation test demonstratesinability of the kidneys to concentrate urinedespite increased plasma osmolality and lowplasma vasopressin level.Vasopressin test demonstrates that the kidneyscan concentrate urine after administration ofADH; this differentiates central (pituitary orhypothalamic) from nephrogenic diabetesinsipidus.
-
8/2/2019 Metab IV Adrenal)
51/119
-
8/2/2019 Metab IV Adrenal)
52/119
Nursing Management
Provide general nursing care for diabetesinsipidus and SIADH.
Assess dehydration, skin turgor, and mucousmembranes.
Provide meticulous skin and mouth care.
Monitor serum electrolyte levels, including sodium
and potassium.
-
8/2/2019 Metab IV Adrenal)
53/119
Provide specific nursing care for diabetesinsipidus.
Administer prescribed medications, which
may include ADH replacements. Replace fluids as indicated. Assess for and
report any illness, injury, or other problemthat could prevent adequate fluid intake.
Encourage the client to drink fluids inresponse to thirst. For some unknownreason, the client craves ice cold water.
-
8/2/2019 Metab IV Adrenal)
54/119
Provide specific nursing care for SIADH.Administer prescribed medications, which mayinclude Furosemide (Lasix), to preventconcentration of urine
Regularly assess mental status.
-
8/2/2019 Metab IV Adrenal)
55/119
Thyroid Gland Disorders
Hypothyroidismstate of insufficient serum thyroid hormone
prevalent in persons between 40 and 50 years old
at least twice as common in women as it is in men.
-
8/2/2019 Metab IV Adrenal)
56/119
-
8/2/2019 Metab IV Adrenal)
57/119
Manifestations
prolonged jaundice after birth, or dry wrinkled skin, aswollen face and tongue that causes noisy respirationand an open mouth that drools
fingers may be broad, and a small hernia at the bellybutton is quite common
baby is usually listless, slow-moving, constipated, anda slow feeder
older children who develop hypothyroidism suddenlystop growing
-
8/2/2019 Metab IV Adrenal)
58/119
-
8/2/2019 Metab IV Adrenal)
59/119
-
8/2/2019 Metab IV Adrenal)
60/119
Risk Factor
Age, weight, and medical history
Women are more likely to develop thedisease after age 50; men, after age 60
Obesity
family history
history of high cholesterol levels
autoimmune diseases as lupus, rheumatoidarthritis, or diabetes mellitus
-
8/2/2019 Metab IV Adrenal)
61/119
Etiology
Primary Hypothyroidism results frompathologic changes in the thyroid glandcaused by: Autoimmune thyroids
Thyroidectomy Radioactive iodine therapy Antithyroid medication therapy
Secondary Hypothyroidism results from
failure of the pituitary gland to secreteadequate TSH, possibly because of atumor, surgical removal, or irradiation.
-
8/2/2019 Metab IV Adrenal)
62/119
Laboratory and diagnostic study findings Thyroid function tests reveal decreased T4 and T3
levels
Serum TSH test reveal increased TSH (primary).
Serum antibody tests detects presence of antithyroidantibodies (autoimmune)
Blood studies reveal elevated cholesterol andcreatine phosphokinase
-
8/2/2019 Metab IV Adrenal)
63/119
Pathophysiology
Inability of the thyroid gland to secrete sufficient
amounts of thyroid hormone, (thyroxine regulatessuch essential functions as heart rate, digestion,physical growth, and mental development, aninsufficient supply of this hormone)
1. leads to decreased cellular metabolic activities2. decreased oxygen consumption
3. decreased heat production
these actions produce mild to marked effects in all
organ systems, can slow life-sustaining processes,damage organs and tissues in every part of the body,and lead to life-threatening complications.
Assessment
-
8/2/2019 Metab IV Adrenal)
64/119
AssessmentClinical Manifestations Sluggishness, lethargy, depression, apathy, fatigue,
and exercise intolerance Memory impairment Muscle aches, numbness and tingling of hands Cold intolerance Constipation
Weight gain and decreased appetite Menstrual irregularities, infertility, and decreased
libido Dry skin, brittle nails and dry hair Possible goiter Delay in muscle contraction and relaxation of tendon
reflexes Bradycardia
M d
-
8/2/2019 Metab IV Adrenal)
65/119
Myxedema coma
extreme complication of hypothyroidism in whichpatients exhibit multiple organ abnormalities andprogressive mental deterioration
refers to the swelling of the skin and soft tissuethat occurs in patients who are hypothyroid
Myxedema coma occurs when the body'scompensatory responses to hypothyroidism areoverwhelmed by a precipitating factor such asinfection.
The cardinal manifestation of myxedema coma isa deterioration of the patient's mental status.
-
8/2/2019 Metab IV Adrenal)
66/119
Myedema coma
Hypotension
Hypoventilation
HypothermiaStupor, possibly progressing to coma
N i M t
-
8/2/2019 Metab IV Adrenal)
67/119
Nursing Management
Provide Pharmacotherapy
Administer prescribed medications, which mayinclude T4
Keep in mind that a client with hypothyroidism isvery sensitive to narcotics, anesthetics, and
sedatives; drug degradation is delayed, andrespiratory depression can develop.
Instruct the client and family members orsignificant others in the prescribed medication
regimen, including purpose dosage schedule, andsigns of overreplacement and underreplacement.
-
8/2/2019 Metab IV Adrenal)
68/119
Administer fluids cautiously, because the clientmay not be able to excrete a heavy water load.If the client has hypoglycemia, infuse aconcentrated source of glucose
Provide relief of constipation, as indicated.
Prevent vascular collapse in a hypothermicclient. Refrain from aggressive rewarming.
Institute respiratory assistance whennecessary.
Implement infection-prevention measures.
-
8/2/2019 Metab IV Adrenal)
69/119
Hyperthyroidism
metabolic imbalance resulting from excessivethyroid hormone production
Graves disease- most common form The incidence of Graves disease is greatest
between the ages of 30-40 and is higheramong women than men.
-
8/2/2019 Metab IV Adrenal)
70/119
Etiology
Autoimmune dysfunction is the most commoncause of Graves disease; autoantibodiesapparently mimic TSH, leading tohypersecretion of thyroid hormones.
Genetic factors seem to play a role. Other possible causes include:
Toxic nodular goiter
Exposure to iodine
TSH-secreting pituitary tumor (rare)Thyroiditis, which may be acute, subacute, orchronic (ie, Hashimoto disease)
-
8/2/2019 Metab IV Adrenal)
71/119
Pathophysiology
Excessive secretion of thyroid hormone- leadsto:
increased metabolic rateexcessive heat production
increased responsiveness to catecholamines
these actions lead to profound changes inmany organ systems.
-
8/2/2019 Metab IV Adrenal)
72/119
Assessment Findings
Clinical Manifestations
Nervousness, irritability, hyperactivity, emotionalexcitability, and decreased attention span
Weakness, easy fatigability, and exercise
intoleranceHeat intolerance
Weight change (loss or gain) and increasedappetite
Insomnia and interrupted sleepFrequent stools and diarrhea
-
8/2/2019 Metab IV Adrenal)
73/119
Menstrual irregularities and decreased libido
Warm, sweaty, flushed skin with a velvety-smoothtexture and spider telangiectasias
Tremor, hyperkinesias, and Hyperreflexia
Exophthalmos, retracted eyelids, and staring gaze
Hair loss
Goiter
Bruits over the thyroid gland
-
8/2/2019 Metab IV Adrenal)
74/119
Thyroid storm:
Hyperthermia, Hypertension, Delirium,Vomiting and abdominal pain,
Tachyarrhythmias
-
8/2/2019 Metab IV Adrenal)
75/119
-
8/2/2019 Metab IV Adrenal)
76/119
Laboratory and Diagnostic Study Findings
Serum thyroid function test reveal increased T4 andT3 levels.
Radioactive iodine uptake test shows an increaseduptake.
Serum TSH assay reveals a nondetectable TSH level.
Thyroid scan reveals increased function (i.e., hotareas) in the thyroid gland.
Nursing Management
-
8/2/2019 Metab IV Adrenal)
77/119
Nursing Management
Administer prescribed medications
Assist the client and family members or significant
others in exploring treatment options. Include familymembers or significant others because the clientsattention span deficit may impair retention ofinformation. Options include:
Pharmacotherapy with drugs that interfere with thyroidhormone synthesis of release
Radioactive iodine therapy permanently limits thyroidhormone secretion by destroying thyroid tissue.Hypothyroidism, requiring lifelong replacement therapy
usually develops at some point after this treatment.Surgery (subtotal or total thyroidectomy). The thyroidlevels must be lowered preoperatively to prevent thyroidstorm; lifelong replacement therapy may be necessary.
-
8/2/2019 Metab IV Adrenal)
78/119
-
8/2/2019 Metab IV Adrenal)
79/119
Prevent Injury
Maintain Normothermia
-
8/2/2019 Metab IV Adrenal)
80/119
Provide post-operative care, if appropriate.Support the head and avoid tension on sutures.
Monitor for complications and intervene asindicated. Hemorrhage requires the nurse to assess the
surgical dressing and sides and back of neck forbleeding.
-
8/2/2019 Metab IV Adrenal)
81/119
Parathyroid Gland Disorders
Hyperparathyroidism
overproduction of PTH, resulting in high bloodcalcium levels and bone demineralization
may be primary or secondary Primary hyperparathyroidism is a common
condition, usually occurring after age 60 andaffecting women more often than men.
-
8/2/2019 Metab IV Adrenal)
82/119
Etiology
Primary HyperparathyroidismAbout 80% of cases are linked to a single
adenoma of the parathyroid gland; the remainingcases are caused by parathyroid hyperplasia.
Secondary hyperparathyroidism results from anadaptive increase in PTH secretion associated
with problems involving chronic hypocalcemia.
Assessment Findings
-
8/2/2019 Metab IV Adrenal)
83/119
Assessment Findings
Clinical Manifestations
Although hyperparathyroidism may beasymptomatic, it may produce the followingsigns and symptoms:
Fatigue, muscular weakness, and listlessness
Height loss and frequent fracturesRenal calculi
Anorexia, nausea, abdominal discomfort, andconstipation
Memory impairment
Polyuria and polydipsia
Back and joint pain
Hypertension
-
8/2/2019 Metab IV Adrenal)
84/119
Laboratory and Diagnostic Study Findings Total and ionized serum calcium levels are elevated
Serum and phosphate levels are decreased
Urinalysis identifies hypercalciuria andhyperphosphaturia
Radiograph or bone densitometry detects bonedemineralization
PTH levels are elevated Parathyroid scan possibly detects abnormal findings
-
8/2/2019 Metab IV Adrenal)
85/119
Nursing ManagementProvide preoperative care.Prepare the client for surgical treatment of primaryhyperparathyroidism, which ,may includeadenoma removal and hyperplastic gland
resection.Force fluids to prevent dehydration, constipation,and kidney stone formation.Reduce added calcium by eliminating over-the-counter antacids, which may contain calcium;thiazide diuretics, which interfere with renalcalcium excretion; and excessive intake of dairyproducts.
-
8/2/2019 Metab IV Adrenal)
86/119
Provide postoperative care, which is similar tothat for thyroidectomy.
As indicated, provide aggressive calciumsupplementation after surgery to compensate
for hungry bone syndrome. Observe the client
for symptoms of hypercalcemia (e.g., nausea,vomiting, headache, mental confusion,anorexia).
Assess for renal calculi; report hematuria orflank pain as necessary.
-
8/2/2019 Metab IV Adrenal)
87/119
Take measures to protect the client frominjury.
Assist with the activities of daily living and
ambulation as necessary.Encourage weight bearing to reducecalcium loss from the bones.
Teach strategies to minimize falls, which
may lead to fractures.
-
8/2/2019 Metab IV Adrenal)
88/119
Provide relief of constipation as indicated; prunejuice, stool softeners, physical activity, andincreased fluids help prevent constipation.
Monitor nutritional status, and intervene asnecessary. Advise the client to avoid a diet withrestricted or excess calcium.
Reinforce the health care follow-up scheduled.
-
8/2/2019 Metab IV Adrenal)
89/119
Hypoparathyroidism
PTH deficiency characterized by
hypocalcemia, hyperphosphatemia, andneuromuscular hyperexcitability.
-
8/2/2019 Metab IV Adrenal)
90/119
Etiology iatrogenic, caused by accidental removal of or
trauma to parathyroid glands during thyroidectomy,parathyroidectomy, or radical head or neck surgery.
autoimmune genetic dysfunction (affects more
women than men). A reversible form may be associated with
hypomagnesemia, which interferes with PTHsecretion.
A Fi di
-
8/2/2019 Metab IV Adrenal)
91/119
Assessment Findings
Clinical Manifestations
Anxiety and irritability
Numbness, tingling, and cramps in extremities
Dysphagia
Photophobia Evidence of neuromuscular hyoerexcitability,
such as positive Chvostek and Trousseausigns, carpopedal spasms, bronchospasms,
laryngeal spasms, arrhythmias, andconvulsion
-
8/2/2019 Metab IV Adrenal)
92/119
Laboratory and diagnostic study findingsTotal and ionized serum calcium levels are low.
Serum phosphate level is elevated.
Serum PTH level is low.
Nursing Management
-
8/2/2019 Metab IV Adrenal)
93/119
Administer prescribed medications, which includecalcium and vitamin D supplements.
Intervene for lie-threatening tetany as indicated.
Administer intravenous calcium gluconateto prevent calcium depletion.
Be alert for possible laryngeal spasm andresulting respiratory obstructions; keep atracheostomy set available.
Institute seizure precautions. Providepadded side rails and bite block at
bedside.Minimize environmental stimuli.
After the crisis resolves, closely monitorcalcium levels. Keep intravenous calcium
gluconate in the clients room.
-
8/2/2019 Metab IV Adrenal)
94/119
Provide care in chronic hypoparathyroidism.
high calcium and low phosphorus diet
Milk, milk products, and egg yolks must beavoided because they are high in phosphorus.
Administer vitamin D and magnesiumsupplementation, as indicated. In clients
receiving magnesium, observe for symptoms ofhypermagnesemia (i.e., hypotension, respiratorydepression, muscle weakness, and confusion.)
Administer oral calcium preparations to
supplement the diet.
-
8/2/2019 Metab IV Adrenal)
95/119
Provide client and family teaching about themedication regimen, including purpose,dosage schedule, and signs and symptoms ofhypocalcemia and hypercalcemia. Inform theclient that the dosage will be adjustedperiodically based on the laboratory findings.
Adrenal Glands Disorders
-
8/2/2019 Metab IV Adrenal)
96/119
Adrenal Glands Disorders
Cushing Syndrome involves excessive production of
adrenocortical hormones, primarily cortisol but
also androgens and mineralocorticoids. Theincident is higher in women than in men.
-
8/2/2019 Metab IV Adrenal)
97/119
Etiology
The most common cause of CushingSyndrome is bilateral adrenal hyperplasia (i.e.,Cushing disease).
Other causes include: Adrenal adenomas and carcinoma
Ectopic ACTH production by tumors in otherorgans, such as the lungs and pancreas.
Glucocorticoid therapy
Assessment Findings
Clinical Manifestations depend on the
-
8/2/2019 Metab IV Adrenal)
98/119
Clinical Manifestations depend on theadrenocortical hormones involved and mayinclude:
Weight gain and altered fat distribution (e.g., centralobesity with round [moon] face and buffalo hump.
Muscle weakness, proximal muscle wasting, and fatigue
Frequent infections and poor wound healing
Symptoms of hyperglycemia Mental status changes and mood swings
Menstrual disturbances, such as amenorrhea
Diminished libido
Skin changes, such as striae, bruises, acne, andthinning of scalp hair
Hypertension
Hirsutism
Susceptibility to compression fractures
Edema
-
8/2/2019 Metab IV Adrenal)
99/119
Laboratory Findings Serum potassium level is decreased.
Serum glucose level is elevated.
WBC count reveals depressed eosinophiland lymphocyte counts.
Diurnal variation plasma levels revealelevated plasma cortisol and 24-hour urine
cortisol results.
-
8/2/2019 Metab IV Adrenal)
100/119
Results for the 24-hour urinary free cortisollevel and 24-hour urine collection for 17-
hydrocorticosteriods and 17-ketosteroids areelevated.
Selected radiographic and axial CT studiesmay determine the site if ectopic ACTH
production
N i M t
-
8/2/2019 Metab IV Adrenal)
101/119
Nursing Management
Administer prescribed medications, which mayinclude adrenocortical steroid inhibitors.Take measures to protect the client from injuryand infection.
Assess skin integrity regularly. Avoid agents that can damage skin (e.g., tape,
strong soaps) Promote good hygiene. Modify the environment to remove or minimize
hazards.
-
8/2/2019 Metab IV Adrenal)
102/119
Prepare the client for surgery, if indicated. Keep in mindthat any treatment modality can cause temporary
adrenal insufficiency. Procedures may include:Adrenalectomy, if the cause is adrenaladenoma
Transsphenoidal hypophysectomy, if the cause
is pituitary adenomaTumor resection
Encourage the client and family to ask questions andverbalize concerns about disease pathology, body
image, treatment, and mental status.
-
8/2/2019 Metab IV Adrenal)
103/119
Addison disease
a primary adrenal hypofunction due tohyposecretion of adrenal cortex hormones.
-
8/2/2019 Metab IV Adrenal)
104/119
Etiology
Addison Disease can result from:
An autoimmune process
Hemorrhage into the adrenal gland
Adrenalectomy
Neoplasm
Fungal infection
Tuberculosis
-
8/2/2019 Metab IV Adrenal)
105/119
Assessment Findings
Clinical Manifestations Addison disease
Gastrointestinal complaints such as anorexia,nausea, vomiting, abdominal pain, and diarrhea
Fatigue, muscle weakness, and arthralgias Decreased alertness and confusion
Weight loss
Dry skin, decreased body hair, and possible
increased pigmentation with excessive ACTHstimulation
-
8/2/2019 Metab IV Adrenal)
106/119
Addisonian (adrenal) CrisisHypotension
Rapid, weak pulse
Rapid respiratory rate
Pallor and extreme weakness
Hyperthermia
-
8/2/2019 Metab IV Adrenal)
107/119
Laboratory and Diagnostic Study Findings Suggestive Findings
Serum blood glucose is decreased.
Serum sodium level is decreased.
Serum potassium level is increased.
WBC cell count is increased.
Definitive Findings
Serum cortisol levels are decreased.ACTH stimulation test reveals a low to normalcortisol response.
N i M t
-
8/2/2019 Metab IV Adrenal)
108/119
Nursing Management
Administer prescribed medications, whichmay include glucocorticosteroids andmineralocorticosteroids.
Provide immediate treatment for an
addisonian crisis. Treatment includesintravenous fluid, glucose, and electrolytes.Corticosteroid replacement andvasopressors may be administered. The
client must avoid exertion.
-
8/2/2019 Metab IV Adrenal)
109/119
Help prevent adrenal crisis. Instruct the client to take precautions to
avoid unnecessary activity and events that
may be stressful. Ensure that hospitalized, acutely ill clients
on a long-term glucocorticoid therapyreceive additional doses to compensate for
stress.
-
8/2/2019 Metab IV Adrenal)
110/119
Provide client and family teaching.
Discuss hormone therapy, including its purpose,side effects, duration, symptoms of abnormalities toreport to health care manager, and the need toinform all health care providers about the steroid
replacement therapy. If overreplacement of glucocorticoids is indicated,
inform the client about the purpose of therapy andpossible side effects, such as cushingoidappearance, weight gain, acne, hirsutism, peptic
ulcer, diabetes mellitus, osteoporosis, infection,muscular weakness, mood swings, cataracts, andhypertension.
-
8/2/2019 Metab IV Adrenal)
111/119
Pheochromocytoma a tumor that is usually benign and originiates
from the chromaffin cells of the adrenal
medulla.
-
8/2/2019 Metab IV Adrenal)
112/119
peak incidence is ages 20-50 years 10% of the tumors are bilateral; 10% are
malignant
stimulates hypersecretion of catecholamines(epinephrine and norepinephrine)
SNS overactivity causing the five Hs:
hypertension, headache, hyperhidrosis,
hypermetabolism, hyperglyclemia
Diagnostic Exams
-
8/2/2019 Metab IV Adrenal)
113/119
Total Plasma Catecholamine Concentration
the client should lie supine and rest for 30minutes
butterfly needle is inserted 30 minutes beforeblood specimen is collected (to prevent elevation
of catecholamine levels by the stress ofvenipuncture)
normal values:Epinephrine: 100 pinogram/ml (590 pmol/L)
Epinephrine: 100 to 550 pinogram/ml (590-3240pmol/L)
-
8/2/2019 Metab IV Adrenal)
114/119
Clonidine Suppression Test
Clonidine (Catapress) a centrally actingadrenergic blocker suppresess the release ofcatocholamines.
in pheochromocytoma, clonidine does not
suppress the release of catecholamines Normal response: 2-3 hours after a single oral
dose of clonidine, the total plasmacatecholamine value decreases at least 40%
from the clients baseline.
-
8/2/2019 Metab IV Adrenal)
115/119
CT scan, MRI, and Ultrasound to localize the pheochromacytoma
-
8/2/2019 Metab IV Adrenal)
116/119
Collaborative Management
Medical Management Bed rest, head of bed elevated during episode
of hypertension, tachycardia, and anxiety toprovide orthostatic decrease in BP.
Pharmacologic therapy
Phentolamine (Regitine)
Sodium Nitroprusside (Nipride) to lower BP quickly
-
8/2/2019 Metab IV Adrenal)
117/119
Surgery Adrenalectomy
Removal of single glands requires
corticosteroid therapy for the first few days orweeks postoperatively
Bilateral removal requires lifetimecorticosteroid therapy
-
8/2/2019 Metab IV Adrenal)
118/119
Nursing Management Teaching the Client Self-Care
Emphasize the importance of periodic follow-up
care.Provide instructions on corticosteroid therapy.
Teach the client and family on how to measure theclients BP.
-
8/2/2019 Metab IV Adrenal)
119/119
End of Chapter!